Please assess the completion status of the following clinical trial:

Trial Title: VQI DELTA Paclitaxel Device Safety Analysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* All patients who underwent endovascular interventional treatment of the femoral or popliteal arteries for symptomatic Peripheral Artery Disease.~Exclusion Criteria:~* In an effort to focus this safety evaluation on those patients being treated in accordance with accepted 'best practice' endovascular intervention strategies and 'on-label' use of devices, patients will be excluded from either exposure cases or controls if they received a balloon expandable stent or a balloon expandable stent graft in the treatment of femoral or popliteal disease. Balloon expandable stents were excluded because these stents have historically shown inferior patency and current best practice favors placement of self-expanding nitinol stents which were engineered for the femoral popliteal segment and tested in multiple trials for this indication 12-14.~Additionally, patients will be excluded (as either potential cases or controls) if their index procedure was performed for acute limb ischemia due to the different etiologies (embolism, in-situ thrombosis) as compared with chronic conditions as they have different treatment paradigms and higher major amputation and mortality rates.~In addition, patients with prior angioplasty or stenting of the superficial femoral artery (SFA)-popliteal segment will be excluded in order to avoid the possibility of improperly assigning paclitaxel exposure to the control group.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Uncoated Balloon Treatment (Type: None): Patients treated for PAD with balloon angioplasty, without use of stent.
- Bare Metal Stent Treatment (Type: None): Patients treated for PAD with implantation of bare metal stent.
- Paclitaxel Coated Balloon (Type: None): Patients treated for PAD with drug coated balloon angioplasty, without use of stent.
- Paclitaxel Eluting Stent (Type: None): Patients treated for PAD with implantation of Paclitaxel DES.

Based on this trial design, predict the completion outcome and termination type (if applicable).